During the past decade, Green Bay Oncology at Saint Vincent Hospital conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 107 clinical trials were completed, i.e. on average, 334.4% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 54 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Green Bay Oncology at Saint Vincent Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 81 trials, followed by "SWOG Cancer Research Network" with 18 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "Gynecologic Oncology Group" with 12 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Green Bay Oncology at Saint Vincent Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 61 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Green Bay Oncology at Saint Vincent Hospital" are "Recurrent Breast Carcinoma" (12 trials), "Recurrent Ovarian Carcinoma" (11 trials), "Ovarian Endometrioid Adenocarcinoma" (9 trials), "Recurrent Fallopian Tube Carcinoma" (8 trials) and "Recurrent Squamous Cell Lung Carcinoma" (8 trials). Many other conditions were trialed in "Green Bay Oncology at Saint Vincent Hospital" in a lesser frequency.

Most popular intervention types in "Green Bay Oncology at Saint Vincent Hospital" are "Drug" (125 trials), "Other" (106 trials), "Biological" (59 trials), "Procedure" (22 trials) and "Radiation" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (77 trials), "Quality-of-Life Assessment" (36 trials), "Paclitaxel" (26 trials), "Bevacizumab" (22 trials) and "Carboplatin" (20 trials). Other intervention names were less common.

The vast majority of trials in "Green Bay Oncology at Saint Vincent Hospital" are 95 trials for "All" genders, 42 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Green Bay Oncology at Saint Vincent Hospital". undefined are not yet recruiting, 5 are recruiting, 64 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Green Bay Oncology at Saint Vincent Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Green Bay Oncology at Saint Vincent Hospital, 6 "Phase 1" clinical trials were conducted, 60 "Phase 2" clinical trials and 80 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".